
### [MONDO:0015855](http://purl.obolibrary.org/obo/MONDO_0015855)
**Label:** isolated congenital breast hypoplasia/aplasia

**Subclasses:** [MONDO:0007238](http://purl.obolibrary.org/obo/MONDO_0007238) (amastia), [MONDO:0014450](http://purl.obolibrary.org/obo/MONDO_0014450) (breasts and/or nipples, aplasia or hypoplasia of, 2), 

**Mapped go classes:** [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0007399](http://purl.obolibrary.org/obo/GO_0007399) (nervous system development), [GO:0048679](http://purl.obolibrary.org/obo/GO_0048679) (regulation of axon regeneration), [GO:0007155](http://purl.obolibrary.org/obo/GO_0007155) (cell adhesion), [GO:0008201](http://purl.obolibrary.org/obo/GO_0008201) (heparin binding), [GO:0043025](http://purl.obolibrary.org/obo/GO_0043025) (neuronal cell body), [GO:0007156](http://purl.obolibrary.org/obo/GO_0007156) (homophilic cell adhesion via plasma membrane adhesion molecules), [GO:0005158](http://purl.obolibrary.org/obo/GO_0005158) (insulin receptor binding), [GO:0042059](http://purl.obolibrary.org/obo/GO_0042059) (negative regulation of epidermal growth factor receptor signaling pathway), [GO:0043005](http://purl.obolibrary.org/obo/GO_0043005) (neuron projection), [GO:0043525](http://purl.obolibrary.org/obo/GO_0043525) (positive regulation of neuron apoptotic process), [GO:0001960](http://purl.obolibrary.org/obo/GO_0001960) (negative regulation of cytokine-mediated signaling pathway), [GO:0030426](http://purl.obolibrary.org/obo/GO_0030426) (growth cone), [GO:0051387](http://purl.obolibrary.org/obo/GO_0051387) (negative regulation of neurotrophin TRK receptor signaling pathway), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0005768](http://purl.obolibrary.org/obo/GO_0005768) (endosome), [GO:0043231](http://purl.obolibrary.org/obo/GO_0043231) (intracellular membrane-bounded organelle), [GO:0016791](http://purl.obolibrary.org/obo/GO_0016791) (phosphatase activity), [GO:0010975](http://purl.obolibrary.org/obo/GO_0010975) (regulation of neuron projection development), [GO:0032403](http://purl.obolibrary.org/obo/GO_0032403) (protein complex binding), [GO:0016311](http://purl.obolibrary.org/obo/GO_0016311) (dephosphorylation), [GO:0035335](http://purl.obolibrary.org/obo/GO_0035335) (peptidyl-tyrosine dephosphorylation), [GO:0016477](http://purl.obolibrary.org/obo/GO_0016477) (cell migration), [GO:0050775](http://purl.obolibrary.org/obo/GO_0050775) (positive regulation of dendrite morphogenesis), [GO:0006470](http://purl.obolibrary.org/obo/GO_0006470) (protein dephosphorylation), [GO:1900121](http://purl.obolibrary.org/obo/GO_1900121) (negative regulation of receptor binding), [GO:0035373](http://purl.obolibrary.org/obo/GO_0035373) (chondroitin sulfate proteoglycan binding), [GO:0060076](http://purl.obolibrary.org/obo/GO_0060076) (excitatory synapse), [GO:0005001](http://purl.obolibrary.org/obo/GO_0005001) (transmembrane receptor protein tyrosine phosphatase activity), [GO:0042301](http://purl.obolibrary.org/obo/GO_0042301) (phosphate ion binding), [GO:0046627](http://purl.obolibrary.org/obo/GO_0046627) (negative regulation of insulin receptor signaling pathway), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0097374](http://purl.obolibrary.org/obo/GO_0097374) (sensory neuron axon guidance), [GO:0004721](http://purl.obolibrary.org/obo/GO_0004721) (phosphoprotein phosphatase activity), [GO:0004725](http://purl.obolibrary.org/obo/GO_0004725) (protein tyrosine phosphatase activity), [GO:0043065](http://purl.obolibrary.org/obo/GO_0043065) (positive regulation of apoptotic process), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0050803](http://purl.obolibrary.org/obo/GO_0050803) (regulation of synapse structure or activity), [GO:0031102](http://purl.obolibrary.org/obo/GO_0031102) (neuron projection regeneration), [GO:0030971](http://purl.obolibrary.org/obo/GO_0030971) (receptor tyrosine kinase binding), [GO:0031345](http://purl.obolibrary.org/obo/GO_0031345) (negative regulation of cell projection organization), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), 

**Class expressions from DL-Learner:**

- [GO:0005539](http://purl.obolibrary.org/obo/GO_0005539) (glycosaminoglycan binding) and [GO:1901681](http://purl.obolibrary.org/obo/GO_1901681) (sulfur compound binding) 58.33%
- [GO:0005539](http://purl.obolibrary.org/obo/GO_0005539) (glycosaminoglycan binding) and [GO:0043168](http://purl.obolibrary.org/obo/GO_0043168) (anion binding) and [GO:1901681](http://purl.obolibrary.org/obo/GO_1901681) (sulfur compound binding) 58.33%
- [GO:0005539](http://purl.obolibrary.org/obo/GO_0005539) (glycosaminoglycan binding) and [GO:0043167](http://purl.obolibrary.org/obo/GO_0043167) (ion binding) and [GO:1901681](http://purl.obolibrary.org/obo/GO_1901681) (sulfur compound binding) 58.33%
- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 54.17%
- [GO:0042301](http://purl.obolibrary.org/obo/GO_0042301) (phosphate ion binding) 54.17%
- [GO:0035373](http://purl.obolibrary.org/obo/GO_0035373) (chondroitin sulfate proteoglycan binding) 54.17%
- [GO:0019198](http://purl.obolibrary.org/obo/GO_0019198) (transmembrane receptor protein phosphatase activity) 54.17%
- [GO:0008201](http://purl.obolibrary.org/obo/GO_0008201) (heparin binding) 54.17%
- [GO:0005158](http://purl.obolibrary.org/obo/GO_0005158) (insulin receptor binding) 54.17%
- [GO:0005001](http://purl.obolibrary.org/obo/GO_0005001) (transmembrane receptor protein tyrosine phosphatase activity) 54.17%
- [GO:0005539](http://purl.obolibrary.org/obo/GO_0005539) (glycosaminoglycan binding) and [GO:0043394](http://purl.obolibrary.org/obo/GO_0043394) (proteoglycan binding) 54.17%
- [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding) and [GO:0005539](http://purl.obolibrary.org/obo/GO_0005539) (glycosaminoglycan binding) 54.17%
- [GO:0005539](http://purl.obolibrary.org/obo/GO_0005539) (glycosaminoglycan binding) and [GO:0043394](http://purl.obolibrary.org/obo/GO_0043394) (proteoglycan binding) and [GO:1901681](http://purl.obolibrary.org/obo/GO_1901681) (sulfur compound binding) 54.17%
- [GO:0005539](http://purl.obolibrary.org/obo/GO_0005539) (glycosaminoglycan binding) and [GO:0043168](http://purl.obolibrary.org/obo/GO_0043168) (anion binding) and [GO:0043394](http://purl.obolibrary.org/obo/GO_0043394) (proteoglycan binding) 54.17%
- [GO:0005539](http://purl.obolibrary.org/obo/GO_0005539) (glycosaminoglycan binding) and [GO:0043167](http://purl.obolibrary.org/obo/GO_0043167) (ion binding) and [GO:0043394](http://purl.obolibrary.org/obo/GO_0043394) (proteoglycan binding) 54.17%


